2023-08-012024-07-312024-07-31false10279084SIGNATURE HEALTHCARE SERVICES LIMITED2025-04-28falseiso4217:GBPxbrli:pure102790842023-08-01102790842024-07-31102790842023-08-012024-07-31102790842022-08-01102790842023-07-31102790842022-08-012023-07-3110279084bus:SmallEntities2023-08-012024-07-3110279084bus:AuditExempt-NoAccountantsReport2023-08-012024-07-3110279084bus:FullAccounts2023-08-012024-07-3110279084bus:PrivateLimitedCompanyLtd2023-08-012024-07-3110279084core:WithinOneYear2024-07-3110279084core:AfterOneYear2024-07-3110279084core:WithinOneYear2023-07-3110279084core:AfterOneYear2023-07-3110279084core:ShareCapital2024-07-3110279084core:SharePremium2024-07-3110279084core:RevaluationReserve2024-07-3110279084core:OtherReservesSubtotal2024-07-3110279084core:RetainedEarningsAccumulatedLosses2024-07-3110279084core:ShareCapital2023-07-3110279084core:SharePremium2023-07-3110279084core:RevaluationReserve2023-07-3110279084core:OtherReservesSubtotal2023-07-3110279084core:RetainedEarningsAccumulatedLosses2023-07-3110279084core:LandBuildings2024-07-3110279084core:PlantMachinery2024-07-3110279084core:Vehicles2024-07-3110279084core:FurnitureFittings2024-07-3110279084core:OfficeEquipment2024-07-3110279084core:NetGoodwill2024-07-3110279084core:IntangibleAssetsOtherThanGoodwill2024-07-3110279084core:ListedExchangeTraded2024-07-3110279084core:UnlistedNon-exchangeTraded2024-07-3110279084core:LandBuildings2023-07-3110279084core:PlantMachinery2023-07-3110279084core:Vehicles2023-07-3110279084core:FurnitureFittings2023-07-3110279084core:OfficeEquipment2023-07-3110279084core:NetGoodwill2023-07-3110279084core:IntangibleAssetsOtherThanGoodwill2023-07-3110279084core:ListedExchangeTraded2023-07-3110279084core:UnlistedNon-exchangeTraded2023-07-3110279084core:LandBuildings2023-08-012024-07-3110279084core:PlantMachinery2023-08-012024-07-3110279084core:Vehicles2023-08-012024-07-3110279084core:FurnitureFittings2023-08-012024-07-3110279084core:OfficeEquipment2023-08-012024-07-3110279084core:NetGoodwill2023-08-012024-07-3110279084core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3110279084core:ListedExchangeTraded2023-08-012024-07-3110279084core:UnlistedNon-exchangeTraded2023-08-012024-07-3110279084core:MoreThanFiveYears2023-08-012024-07-3110279084core:Non-currentFinancialInstruments2024-07-3110279084core:Non-currentFinancialInstruments2023-07-3110279084dpl:CostSales2023-08-012024-07-3110279084dpl:DistributionCosts2023-08-012024-07-3110279084core:LandBuildings2023-08-012024-07-3110279084core:PlantMachinery2023-08-012024-07-3110279084core:Vehicles2023-08-012024-07-3110279084core:FurnitureFittings2023-08-012024-07-3110279084core:OfficeEquipment2023-08-012024-07-3110279084dpl:AdministrativeExpenses2023-08-012024-07-3110279084core:NetGoodwill2023-08-012024-07-3110279084core:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3110279084dpl:GroupUndertakings2023-08-012024-07-3110279084dpl:ParticipatingInterests2023-08-012024-07-3110279084dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-012024-07-3110279084core:ListedExchangeTraded2023-08-012024-07-3110279084dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-012024-07-3110279084core:UnlistedNon-exchangeTraded2023-08-012024-07-3110279084dpl:CostSales2022-08-012023-07-3110279084dpl:DistributionCosts2022-08-012023-07-3110279084core:LandBuildings2022-08-012023-07-3110279084core:PlantMachinery2022-08-012023-07-3110279084core:Vehicles2022-08-012023-07-3110279084core:FurnitureFittings2022-08-012023-07-3110279084core:OfficeEquipment2022-08-012023-07-3110279084dpl:AdministrativeExpenses2022-08-012023-07-3110279084core:NetGoodwill2022-08-012023-07-3110279084core:IntangibleAssetsOtherThanGoodwill2022-08-012023-07-3110279084dpl:GroupUndertakings2022-08-012023-07-3110279084dpl:ParticipatingInterests2022-08-012023-07-3110279084dpl:GroupUndertakingscore:ListedExchangeTraded2022-08-012023-07-3110279084core:ListedExchangeTraded2022-08-012023-07-3110279084dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-08-012023-07-3110279084core:UnlistedNon-exchangeTraded2022-08-012023-07-3110279084core:NetGoodwill2024-07-3110279084core:IntangibleAssetsOtherThanGoodwill2024-07-3110279084core:LandBuildings2024-07-3110279084core:PlantMachinery2024-07-3110279084core:Vehicles2024-07-3110279084core:FurnitureFittings2024-07-3110279084core:OfficeEquipment2024-07-3110279084core:AfterOneYear2024-07-3110279084core:WithinOneYear2024-07-3110279084core:ListedExchangeTraded2024-07-3110279084core:UnlistedNon-exchangeTraded2024-07-3110279084core:ShareCapital2024-07-3110279084core:SharePremium2024-07-3110279084core:RevaluationReserve2024-07-3110279084core:OtherReservesSubtotal2024-07-3110279084core:RetainedEarningsAccumulatedLosses2024-07-3110279084core:NetGoodwill2023-07-3110279084core:IntangibleAssetsOtherThanGoodwill2023-07-3110279084core:LandBuildings2023-07-3110279084core:PlantMachinery2023-07-3110279084core:Vehicles2023-07-3110279084core:FurnitureFittings2023-07-3110279084core:OfficeEquipment2023-07-3110279084core:AfterOneYear2023-07-3110279084core:WithinOneYear2023-07-3110279084core:ListedExchangeTraded2023-07-3110279084core:UnlistedNon-exchangeTraded2023-07-3110279084core:ShareCapital2023-07-3110279084core:SharePremium2023-07-3110279084core:RevaluationReserve2023-07-3110279084core:OtherReservesSubtotal2023-07-3110279084core:RetainedEarningsAccumulatedLosses2023-07-3110279084core:NetGoodwill2022-08-0110279084core:IntangibleAssetsOtherThanGoodwill2022-08-0110279084core:LandBuildings2022-08-0110279084core:PlantMachinery2022-08-0110279084core:Vehicles2022-08-0110279084core:FurnitureFittings2022-08-0110279084core:OfficeEquipment2022-08-0110279084core:AfterOneYear2022-08-0110279084core:WithinOneYear2022-08-0110279084core:ListedExchangeTraded2022-08-0110279084core:UnlistedNon-exchangeTraded2022-08-0110279084core:ShareCapital2022-08-0110279084core:SharePremium2022-08-0110279084core:RevaluationReserve2022-08-0110279084core:OtherReservesSubtotal2022-08-0110279084core:RetainedEarningsAccumulatedLosses2022-08-0110279084core:AfterOneYear2023-08-012024-07-3110279084core:WithinOneYear2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:CostValuation2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-012024-07-3110279084core:Non-currentFinancialInstrumentscore:CostValuation2024-07-3110279084core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-07-3110279084core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-07-3110279084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-07-3110279084core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-07-3110279084core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-07-3110279084core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-07-3110279084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-07-3110279084core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-07-3110279084core:Non-currentFinancialInstrumentscore:CostValuation2023-07-3110279084core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-3110279084core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-3110279084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-3110279084core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-3110279084core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-3110279084core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-3110279084core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-3110279084core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-3110279084bus:Director12023-08-012024-07-3110279084core:FurnitureFittingsToolsEquipment2023-07-3110279084core:FurnitureFittingsToolsEquipment2023-08-012024-07-3110279084core:FurnitureFittingsToolsEquipment2024-07-31

SIGNATURE HEALTHCARE SERVICES LIMITED

Registered Number
10279084
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2024

SIGNATURE HEALTHCARE SERVICES LIMITED
Company Information
for the year from 1 August 2023 to 31 July 2024

Director

SAMANI, Reece

Registered Address

Unit 9 Concord Business Centre
Concord Road
London
W3 0TJ

Registered Number

10279084 (England and Wales)
SIGNATURE HEALTHCARE SERVICES LIMITED
Balance Sheet as at
31 July 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3116,927135,161
Tangible assets4784,650731,797
901,577866,958
Current assets
Stocks542,13030,500
Debtors6656,960522,358
Cash at bank and on hand368,77586,033
1,067,865638,891
Creditors amounts falling due within one year7(886,002)(638,104)
Net current assets (liabilities)181,863787
Total assets less current liabilities1,083,440867,745
Creditors amounts falling due after one year8(403,031)(530,508)
Net assets680,409337,237
Capital and reserves
Called up share capital1,0001,000
Profit and loss account679,409336,237
Shareholders' funds680,409337,237
The financial statements were approved and authorised for issue by the Director on 28 April 2025, and are signed on its behalf by:
SAMANI, Reece
Director
Registered Company No. 10279084
SIGNATURE HEALTHCARE SERVICES LIMITED
Notes to the Financial Statements
for the year ended 31 July 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover relates to fees receivable in respect of the provision of online pharmacy sales, net of VAT and trade discounts.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. Intangible assets are being amortised evenly over their estimated useful life of ten years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Land and buildings1-
Plant and machinery25-
Fixtures and fittings15-
Vehicles25-
Office Equipment-3
Stocks and work in progress
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
2.Average number of employees

20242023
Average number of employees during the year93
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 August 23170,791170,791
Additions1,1851,185
At 31 July 24171,976171,976
Amortisation and impairment
At 01 August 2335,63035,630
Charge for year19,41919,419
At 31 July 2455,04955,049
Net book value
At 31 July 24116,927116,927
At 31 July 23135,161135,161
4.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

££££££
Cost or valuation
At 01 August 23574,53337,04868,64772,9855,844759,057
Additions91,2432,049--7,974101,266
At 31 July 24665,77639,09768,64772,98513,818860,323
Depreciation and impairment
At 01 August 239581,54419,3071,8253,62627,260
Charge for year6,5009,17512,33517,7902,61348,413
At 31 July 247,45810,71931,64219,6156,23975,673
Net book value
At 31 July 24658,31828,37837,00553,3707,579784,650
At 31 July 23573,57535,50449,34071,1602,218731,797
5.Stocks

2024

2023

££
Finished goods42,13030,500
Total42,13030,500
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables289,051182,230
Other debtors81,33930,604
Prepayments and accrued income7,348311
Total377,738213,145
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables411,609207,137
Bank borrowings and overdrafts107,869125,066
Taxation and social security154,30964,600
Other creditors59,043119,802
Accrued liabilities and deferred income153,172121,499
Total886,002638,104
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts403,031487,789
Other creditors-42,719
Total403,031530,508
9.Related party transactions
Included in other debtors is a balance amounting to £279,222 (2023: £309213) due from Lopic Ltd, a company in which Mr R Samani is a director.